Biomedical Research and Training Institute
9
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
Role: collaborator
Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe
Role: collaborator
Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe
Role: collaborator
Same Day Diagnosis of Extrapulmonary TB (TB Serositis and TB Meningitis).
Role: collaborator
An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check)
Role: collaborator
Community Based Interventions to Improve HIV Outcomes in Youth: a Cluster Randomised Trial in Zimbabwe
Role: collaborator
Manicaland Cash Transfer Trial for Children in Zimbabwe
Role: collaborator
Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Role: collaborator
Trial of Point-of-treatment Xpert MTB/RIF Assay
Role: collaborator
All 9 trials loaded